Pacific Biosciences Of California, INC. (PACB) SEC Filings — 2025
16 SEC filings for Pacific Biosciences Of California, INC. (PACB) in 2025.
Filings
- PacBio's Q3 Loss Widens Amid Soaring Intangible Asset Amortization — 10-Q · Nov 6, 2025
- Pacific Biosciences Of California, INC. 8-K Filing — 8-K · Nov 5, 2025
- PacBio's Q2 Revenue Jumps 33% on Strong Product Sales — 10-Q · Aug 7, 2025
- PacBio Reports Director Changes and Executive Appointments — 8-K · Jun 6, 2025
- PacBio Files Proxy Materials — DEFA14A · May 20, 2025
- PacBio Files Q1 2025 10-Q — 10-Q · May 12, 2025
- PACB Files 8-K on Operations and Financials — 8-K · May 8, 2025
- PacBio Files DEF 14A: Executive Compensation Details — DEF 14A · Apr 23, 2025
- PacBio Files 8-K on Financials and Exit Costs — 8-K · Apr 9, 2025
- PacBio CFO Departs; New Directors Appointed — 8-K · Mar 27, 2025
- PacBio Files 2024 10-K, Details Financials — 10-K · Mar 17, 2025
- PacBio Enters Material Definitive Agreement — 8-K · Mar 13, 2025
- PacBio Files 8-K on Financials — 8-K · Feb 13, 2025
- PacBio Files 8-K/A Amendment on Officer/Director Changes — 8-K/A · Feb 7, 2025
- PacBio Announces Director Changes and Compensatory Arrangements — 8-K · Jan 30, 2025
- PacBio Files 8-K on Operations and Financials — 8-K · Jan 14, 2025